StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.97−0.45 (-1.70%)

Close on Nov 17, 2026Market cap $996.68MP/E –Yield –

Ceribell revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Ceribell's revenue for the twelve months ending Jun 30, 2026 was $101.96M, up 31.7% year over year. For fiscal 2025 it was $89.06M, up 36.1% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$89.06M+36.1%
FY2024Dec 31, 2024$65.44M+44.7%
FY2023Dec 31, 2023$45.23M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.10M+32.5%
Q1 FY2026Mar 31, 2026$26.49M+29.3%
Q4 FY2025Dec 31, 2025$24.78M+33.7%
Q3 FY2025Sep 30, 2025$22.59M+31.4%
Q2 FY2025Jun 30, 2025$21.20M+38.4%
Q1 FY2025Mar 31, 2025$20.49M+42.3%
Q4 FY2024Dec 31, 2024$18.53M+41.1%
Q3 FY2024Sep 30, 2024$17.20M+48.1%
Q2 FY2024Jun 30, 2024$15.32M–
Q1 FY2024Mar 31, 2024$14.40M–
Q4 FY2023Dec 31, 2023$13.13M–
Q3 FY2023Sep 30, 2023$11.61M–

More Ceribell figures

See a number that looks wrong?